CTI BioPharma Corp. (GB:0RLB)

CTI BioPharma (0RLB) Financial Statements


CTI BioPharma Financial Overview

CTI BioPharma's market cap is currently ―. The company's EPS TTM is €-0.552; its P/E ratio is -1.17; CTI BioPharma is scheduled to report earnings on August 3, 2023, and the estimated EPS forecast is €-0.07. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 24.12M$ 21.08M$ 18.24M$ 12.33M$ 2.29M
Gross Profit$ 25.34M$ 19.92M$ 17.09M$ 11.41M$ 2.02M
EBIT$ 57.46M$ -13.71M$ -11.71M$ -18.68M$ -35.10M
EBITDA$ 57.98M$ -13.18M$ -11.17M$ -18.11M$ -34.78M
Net Income Common Stockholders$ 53.27M$ -17.46M$ -15.71M$ -22.65M$ -37.17M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 59.01M$ 79.94M$ 81.64M$ 95.87M$ 96.90M
Total Assets$ 112.27M$ 125.92M$ 123.47M$ 134.53M$ 131.44M
Total Debt$ 48.08M$ 47.94M$ 49.24M$ 49.30M$ 48.34M
Net Debt$ -10.93M$ -32.00M$ -32.40M$ -46.57M$ -48.56M
Total Liabilities$ 137.62M$ 143.50M$ 140.30M$ 139.81M$ 159.35M
Stockholders Equity$ -25.35M$ 248.92M$ -16.84M$ -5.27M$ -27.92M
Cash Flow-
Free Cash Flow$ -31.10M$ -15.51M$ -40.46M$ -20.24M$ -29.98M
Operating Cash Flow$ -31.10M$ -15.51M$ -15.46M$ -20.24M$ -29.98M
Investing Cash Flow$ 15.26M$ 537.00K$ -19.60M$ -54.79M$ 0.00
Financing Cash Flow$ 9.63M$ 13.35M$ 1.02M$ 44.22M$ 61.43M
Currency in USD

CTI BioPharma Earnings and Revenue History

CTI BioPharma Debt to Assets

CTI BioPharma Cash Flow

CTI BioPharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis